Schulhoff & Co’s Edwards Lifesciences EW Stock Holding History

Schulhoff & Co’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$229K	Hold	2,856	–	–	0.09%	125
2025 Q4	$243K	Hold	2,856	–	–	0.1%	124
2025 Q3	$221K	Hold	2,856	–	–	0.09%	131
2025 Q2	$223K	Hold	2,856	–	–	0.1%	128
2025 Q1	$207K	Buy	+2,856	New	+$204K	0.09%	126
2024 Q3	–	Sell	-2,856	Closed	-$264K	–	129
2024 Q2	$264K	Hold	2,856	–	–	0.12%	104
2024 Q1	$273K	Hold	2,856	–	–	0.12%	101
2023 Q4	$218K	Buy	+2,856	New	+$199K	0.1%	114
2023 Q3	–	Sell	-2,856	Closed	-$269K	–	121
2023 Q2	$269K	Hold	2,856	–	–	0.13%	98
2023 Q1	$236K	Hold	2,856	–	–	0.11%	105
2022 Q4	$213K	Hold	2,856	–	–	0.1%	111
2022 Q3	$235K	Hold	2,856	–	–	0.12%	99
2022 Q2	$271K	Hold	2,856	–	–	0.13%	90
2022 Q1	$336K	Hold	2,856	–	–	0.14%	91
2021 Q4	$369K	Hold	2,856	–	–	0.15%	86
2021 Q3	$323K	Hold	2,856	–	–	0.15%	90
2021 Q2	$295K	Hold	2,856	–	–	0.13%	98
2021 Q1	$238K	Hold	2,856	–	–	0.11%	103
2020 Q4	$260K	Hold	2,856	–	–	0.13%	94
2020 Q3	$227K	Buy	+2,856	New	+$223K	0.12%	94
2020 Q1	–	Sell	-2,856	Closed	-$222K	–	103
2019 Q4	$222K	Hold	2,856	–	–	0.1%	103
2019 Q3	$209K	Buy	+2,856	New	+$201K	0.1%	102

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Schulhoff & Co's EW Position: Q1 2026 in Review

Schulhoff & Co held its Edwards Lifesciences (EW) position steady in Q1 2026 at 2,856 shares worth $229K. The position accounts for 0.09% of the portfolio, ranked #125.

Schulhoff & Co first reported a position in EW in Q3 2019 and has held it in 22 quarters since. The position peaked at $369K in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Schulhoff & Co held 2,856 shares of Edwards Lifesciences worth $229K as of Q1 2026.
Schulhoff & Co left its Edwards Lifesciences share count unchanged in Q1 2026.
Edwards Lifesciences made up 0.09% of Schulhoff & Co's portfolio in Q1 2026, its #125 holding.
Schulhoff & Co first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 22 quarters since.
Schulhoff & Co's Edwards Lifesciences position peaked at $369K in Q4 2021.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Schulhoff & Co's 13F filing for Q1 2026, filed 11 May 2026.